NfL Blood Biomarker Captures Suboptimal Treatment Response in MS NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Measuring levels of neurofilament light chain is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple sclerosis, independent of other measures, a new study shows.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news